Introduction With every article of the Microbiome Times, one sees the therapeutic microbiome industry edging ever-closer to full commercialisation of their products. Understandably, much of the focus has been on the challenging process of demonstrating […]
Many different chronic diseases have been associated with distinct gut microbiome ‘signatures’, but what has proved challenging to date is the translation of the compositional and functional microbiome differences into novel diagnostics and therapeutics. Moving […]
The human microbiome is often described as an ‘ecosystem’, evoking a complex collection of organisms that are alive and dynamic. So when considering strategies for modulating the human microbiome to prevent or treat a disease, […]
First, it was a bank teller who mentioned to me she’d learned about the skin microbiome from a Dove commercial. Then it was a woman whose drink I’d accidentally touched at the Starbucks counter, who […]
The overlap between the gut microbiome and tumor progression, metastasis and treatment sensitivity is one of the fastest growing areas of cancer research1. Recent studies have demonstrated that the microbiome plays important roles in oncogenesis […]
Human microbiome research is one of the most relevant fields of innovation based on the large range of applications known and sectors currently or potentially involved. In fact, the US therapeutics market is meant to […]
This month’s roundup begins with a paper describing what happens when bifidobacteria in the infant gut degrade human milk oligosaccharides; and another about the role of the infant airway microbiota in predicting later-life asthma. Next […]
Below are October’s must-read scientific papers on the microbiome and human health. The first highlighted paper this month expands what we know about viruses, the tiniest members of the gut microbiota, which are often eclipsed […]
The “Million Microbiome of Humans Project” (MMHP) was officially launched at the 14th International Conference on Genomics (ICG-14). Scientists from China, Sweden, Denmark, France, Latvia and other countries will cooperate in microbial metagenomic research, aiming […]
Many individuals living with chronic disease—whether it’s asthma, allergies, atopic dermatitis, type 2 diabetes, or another condition—readily confirm their therapeutic options leave a lot to be desired. Even if an existing drug product deals adequately […]
